Federal grants to Benaroya Research Institute at Virginia Mason
Benaroya Research Institute at Virginia Mason in Seattle, Washington received $268 million in federal grants from fiscal 2021 to 2025, across 59 awards. Its largest program was Allergy and Infectious Diseases Research, with $223 million. In fiscal 2025 it was awarded $41.7 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$268 million
- Awards59
- Awarded in FY 2025$41.7 million
- Largest award$183 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 23 | $69.8 million |
| FY 2022 | 25 | $47.0 million |
| FY 2023 | 29 | $54.8 million |
| FY 2024 | 29 | $55.1 million |
| FY 2025 | 25 | $41.7 million |
Programs that fund Benaroya Research Institute at Virginia Mason
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 38 | $223 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 8 | $28.1 million |
| Trans-NIH Research Support | 8 | $10.2 million |
| Cancer Treatment Research | 1 | $2.6 million |
| Cardiovascular Diseases Research | 2 | $2.4 million |
| Arthritis, Musculoskeletal and Skin Diseases Research | 1 | $1.7 million |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 1 | $475,764 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 59 | $268 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Immune tolerance network | Allergy and Infectious Diseases Research | December 30, 2020 | $183 million |
| Immune tolerance network | Diabetes, Digestive, and Kidney Diseases Extramural Research | August 26, 2021 | $13.7 million |
| Systems immunology profiling of respiratory viral infections in vulnerable populations - summary/abstract – overall acute respiratory viral infections (ARVI) are the most frequently occurring global illness producing significant morbidity and mortality, particularly in vulnerable populations. Childr | Allergy and Infectious Diseases Research | March 29, 2022 | $9.4 million |
| Type 1 diabetes trialnet clinical network hub | Diabetes, Digestive, and Kidney Diseases Extramural Research | June 3, 2021 | $4.0 million |
| Harnessing engineered t regulatory cells to promote beta cell health in T1D - summary type 1 diabetes (T1D) is characterized by the destruction of ss-cells, driven through autoimmune attack directed at the pancreatic islet. In concert with ss-cell destruction, ss-cell stress and injury contribute to | Diabetes, Digestive, and Kidney Diseases Extramural Research | April 7, 2022 | $3.9 million |
| Mechanistic and functional dissection of inflammaging in down syndrome - project summary/abstract the immune system becomes functionally impaired with aging (inflammaging), impacting risk and outcome of infection, vaccination, cancer, cardiovascular disease and autoimmunity. Individuals with down sy | Trans-NIH Research Support | August 29, 2022 | $3.2 million |
| Commensal-specific t cell function in skin wound repair - project summary our understanding of immunity largely stems from models of infection with pathogenic microbes. However, the vast majority of microbial-immune encounters occur as a symbiotic relationship with the commensal microbiota. Recently | Allergy and Infectious Diseases Research | February 1, 2021 | $2.9 million |
| Allergen t cell epitopes and phenotypes in peanut allergy and immunotherapy | Allergy and Infectious Diseases Research | December 11, 2020 | $2.8 million |
| Bcap regulation of TLR7/9 signaling in lupus | Allergy and Infectious Diseases Research | November 20, 2020 | $2.8 million |
| T cells promoting transitions toward autoimmunity - summary autoimmune disease results from a combination of immunologic missteps involving multiple genes, cell types and environmental factors. In the proposed studies, we will study how these factors promote the transition from sub-clinical autoimmu | Trans-NIH Research Support | August 18, 2023 | $2.7 million |
Questions people ask
How much federal grant money does Benaroya Research Institute at Virginia Mason get?
$268 million in 59 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Benaroya Research Institute at Virginia Mason the most?
The Department of Health and Human Services, with $268 million in 59 awards.
What is Benaroya Research Institute at Virginia Mason's largest federal grant?
$183 million under Allergy and Infectious Diseases Research, with its first action in the period on December 30, 2020. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Benaroya Research Institute at Virginia Mason?
Its largest are Allergy and Infectious Diseases Research, Diabetes, Digestive, and Kidney Diseases Extramural Research and Trans-NIH Research Support.
Other grant recipients in Seattle
- University of Washington
- Central Puget Sound Regional Transit Authority
- Fred Hutchinson Cancer Center
- King County Metro Transit
- Port of Seattle
- Seattle Children's Hospital
- Allen Institute
- Seattle Housing Authority
Largest federal grant recipients in Washington · Federal grants in Washington